#orforglipron

4 articles tagged #orforglipron.

#2026 3#503a 1#503b 2#FDA 1#alternatives 1#ban 1#before-and-after 1#beginners 2#brand-name 3#bridge-program 2#comparison 2#compounded 7#compounded-semaglutide 1#compounded-tirzepatide 1#compounding-ban 1#copay 1#cost 12#countdown 1#coupon 1#coverage 1#diabetes 1#diet 1#dosage 1#eli-lilly 3#enforcement 1#enrollment 1#fact-check 1#fda 3#fda-approval 1#flat-rate 1#foundayo 6#framework 1#glp-1-patches 1#glucose-monitors 1#guide 1#hhs 1#hims 1#how-to-get 1#injectable 5#injection 1#insurance 11#ivy-rx 1#ivyrx 1#legality 1#liraglutide 1#medicaid 1#medicare 6#mounjaro 5#news 3#novo-nordisk 1#oral-glp1 6#oral-semaglutide 1#orforglipron 4#ozempic 5#pill 1#policy 1#prior-authorization 1#regulation 2#results 1#rfk 1#ro 1#safety 3#savings-card 1#schedule 1#semaglutide 16#shortage 1#side-effects 9#supplements 1#surmount 2#telehealth-review 1#timeline 1#tirzepatide 17#wegovy 15#wegovy-pill 3#weight-loss 24#without-insurance 1#zepbound 17
Editorial lifestyle photograph illustrating a morning wellness routine with a glass of water on a clean kitchen counter
GuideComparisonsMay 20, 2026• 10 min read

Oral GLP-1 Pills for Weight Loss (2026): Foundayo, Wegovy Pill & All Options Compared

As of 2026, two FDA-approved oral GLP-1 pills exist for weight loss: Foundayo (orforglipron, 12.4% weight loss, $149/mo self-pay via LillyDirect, no fasting needed, approved April 1) and the Wegovy pill (semaglutide 25mg, 16.6% weight loss, $1,349/mo list price, requires 30-min fast before dosing, approved December 2025). Rybelsus is oral semaglutide but approved for type 2 diabetes only — not weight loss.

Editorial still-life illustrating Foundayo and Wegovy pill comparison for weight loss
AnalysisComparisonsMay 11, 2026• 20 min read

Foundayo vs Wegovy Pill (2026): 16.6% vs 12.4% Weight Loss — $149 vs $1,349/mo Self-Pay

Updated May 18, 2026 with Week 5 IQVIA data: 10,248 weekly Rx (+40% week-over-week re-acceleration). Oral Wegovy produces 16.6% body weight loss vs Foundayo's 12.4%, but Foundayo starts at $149/mo self-pay (WAC $649/mo) vs Wegovy's $1,349/mo and has no fasting requirement. PBM formulary activation expected to drive Week 6 acceleration. Full comparison with OASIS and ATTAIN trial data.

Editorial lifestyle photograph illustrating a guide to Foundayo orforglipron oral GLP-1
GuideGuidesApril 29, 2026• 14 min read

Foundayo (Orforglipron) Guide 2026: $649/mo, 12.4% Weight Loss, No Fasting Required

Updated April 29, 2026: Foundayo (orforglipron) is the first non-peptide GLP-1 pill for weight loss, FDA-approved April 1, 2026. Produces 12.4% body weight loss over 72 weeks per ATTAIN-1 trial. ACHIEVE-4 (April 2026): 57% lower all-cause death vs insulin glargine (HR 0.43, 2,700 patients). Self-pay starts at $149/month (starting dose) via LillyDirect, $299/month at maintenance doses. No food or water restrictions — take any time.

Top Picks

Four programs our readers click through most.

Eden Health GLP-1

8.9/10
$249/mo·Brand & Compounded
Visit Eden Health GLP-1Review

Embody

7.3/10
$299/mo·Compounded
Visit EmbodyReview

Gala

7.2/10
$149/mo·Brand & Compounded
Visit GalaReview

Affiliate links — we earn a commission at no extra cost to you. Selection reflects what readers convert through, not editorial endorsement. Full ranking + methodology at glp1picks.com.

Top 3 Picks

Eden Health GLP-1$249/moVisit
Embody$299/moVisit
Gala$149/moVisit
or compare all 48 →